Jump to content

Protek Pharmaceuticals

From Wikipedia, the free encyclopedia
Protek
MCXPRTK
Founded1990
Headquarters,
Russia
Revenue$4.43 billion[1] (2017)
$138 million[1] (2017)
$101 million[1] (2017)
Total assets$2.32 billion[1] (2017)
Total equity$579 million[1] (2017)
Number of employees
15,300

Protek (Russian: Протек) is a Russian company that includes drug manufacturing, retail, and distribution. It is one of the largest pharmaceutical companies of Russia.[2] It was founded in 1990 by Vadim Yakunin and Grigor Khachaturov.[3] In 2022, the company's revenue in Russia amounted to 257 billion rubles.[4]

See also

[edit]

References

[edit]
  1. ^ a b c d e http://www.protek-group.ru/upload/iblock/761/PAO-PROTEK_MSFO_KFO_2017.pdf. {{cite web}}: Missing or empty |title= (help)
  2. ^ "Russia - Country Commercial Guide - Pharmaceuticals". International Trade Administration (which operates trade.gov). 2020-11-14. Retrieved June 17, 2021.
  3. ^ "Russian drug firm Protek in talks with new partner". Reuters. Archived from the original on 2022-12-18.
  4. ^ "АО ЦВ Протек". www.rusprofile.ru (in Russian). Retrieved 2023-11-30.